4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001413350-26-000004
Director bought 589 shares at $1.78 ($1,048)
- Director acquired 224,152 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venkatesan Jay Director | 2026-05-22 | Purchase | +589 | $1.78 | $1,048 | 589 | D |
| Venkatesan Jay Director | 2026-06-17 | Conversion | +224,152 | $2.25 | $504,342 | 231,705 | I |
| Derivatives | |||||||
| Venkatesan Jay Director | 2026-06-17 | Grant or award · Stock Option (right to buy) | +15,250 | 15,250 | D | ||
| Venkatesan Jay Director | 2026-06-17 | Conversion · Series A Convertible Preferred Stock | −96,525 | $2.25 | $217,181 | 0 | I |
| Open-market purchases · 589 sh · avg $1.78 · $1,048 | |||||||
Loading xslF345X06/wk-form4_1782170099.xml…